Skip to content

Efficacy of vonoprazan fumarate in the treatment of peptic ulcers

Efficacy of vonoprazan fumarate in the treatment of peptic ulcers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111632
Enrollment
Unknown
Registered
2025-11-03
Start date
2022-05-31
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic ulcer

Interventions

Rabeprazole oral group:Rabeprazole 20mg, once a day
Vonoprazan fumarate oral group:Vonoprazan fumarate 20mg, once a day
Pantoprazole oral group:Pantoprazole 40mg, once a day

Sponsors

Xiamen Humanity hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Over 18 years old; 2. Before being included in the study, all were confirmed by gastroscopy to meet the standards for peptic ulcer set by the World Health Organization.

Exclusion criteria

Exclusion criteria: 1. Have an allergic reaction to the drug in this study; 2. Those with severe heart and lung diseases, blood system diseases, malignant tumors, weakened immune function, hemorrhagic diseases, or liver and kidney insufficiency; 3. Lactating or pregnant women; 4. Those with severe neurological diseases or mental disorders who are unable to take medication as prescribed; 5. Digestive tract tumors or ulcers with malignant lesions not ruled out, special ulcers (pyloric canal ulcers, giant ulcers (ulcer diameter greater than 2cm), Dieulafoy ulcers, refractory ulcers); 6. There are severe ulcer complications such as perforation and pyloric obstruction; 7. There is active bleeding or hemorrhagic shock; 8. Within one week prior to inclusion in the study, the patient had used PPI, H2 receptor blockers, P-CAB drugs, bismuth agents, mucosal protectants, or antibiotics.

Design outcomes

Primary

MeasureTime frame
Ulcer healing under endoscopy;

Secondary

MeasureTime frame
HP eradication rate;

Countries

China

Contacts

Public ContactRongchun Zhang

Xiamen Humanity hospital

376092701@qq.com+86 592 526 2211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026